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Abstract: It could be postulated that due to lifestyle factors, patients with poor antiretroviral therapy (ART) adherence 
may also have risky sexual behaviour potentially leading to HIV transmission. There are limited data regarding 
unprotected sex risk and ART adherence in resource limited settings and our study set out to investigate these in an HIV 
clinic in Bangkok. Patients completed an anonymous questionnaire regarding their relationship details, ART adherence, 
sexual behaviour, alcohol and drug use and HIV transmission beliefs. Laboratory findings and medical history were also 
collected. Unprotected sex risk (USR) was defined as inconsistent condom use with a partner of negative or unknown HIV 
status. Five hundred and twelve patients completed the questionnaire. Fifty seven per cent of patients reported having 
taken ARV >95% of the time in the last month and 58% had been sexually active in the previous 30 days. Only 27 
patients (5%) were classified as having USR in our cohort. Multivariate analysis showed USR was associated with female 
gender (OR 2.9, 95% CI 1.2-7.0, p0.02) but not with adherence, age, type or number of partners, recreational drug or 
alcohol use nor beliefs about HIV transmission whilst taking ART. Levels of USR in this resource limited setting were 
reassuringly low and not associated with poor ART adherence; as all USR patients had undetectable viral loads onward 
HIV transmission risk is likely to be low but not negligible. Nonetheless condom negotiation techniques, particularly in 
women, may be useful in this group. 
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INTRODUCTION 
  It is well established that adherence to effective 
antiretroviral treatment (ART) is essential for viral control 
and hence survival in HIV/AIDS [1]. Earlier studies have 
shown that ART requires strict dosing schedules for it to be 
maximally effective, i.e. adherence of >95% is needed for 
optimal viral suppression in patients taking protease 
inhibitor-based regimens [2]. More recent studies suggest 
that adherence of 80% (or even less in some patients) may be 
sufficient for suppression in the current era of more effective 
ART, particularly with a longer duration on ART[3, 4]. 
  Having a low serum viral load (VL) is known to be 
associated with much lower risks of transmission of HIV [5, 
6]. However it has been shown that a low plasma viral load 
does not always correlate with a low genital HIV viral load 
so transmission could still potentially occur in this situation 
[7-9]. Yet several studies have shown none or few 
heterosexual transmissions when a partner is on ART, 
including a recent randomised controlled international study,  
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HPTN052 showing a 96% transmission in discordant 
couples if the infected person takes ART [10, 11]. 
  There has been conflicting information regarding the 
impact of ART use and sexual behaviour: some studies 
(particularly in resource rich countries) showing increased 
risk behaviour [12] while others showing a reduction in risk 
behaviour with ART [13-16] . One study suggested that 
since ART availability there may be some evidence of 
increased risky behaviour in non-HIV infected people [17]. 
Several studies have shown that the belief that having an 
undetectable viral load leads to lower infectiousness is 
associated with greater number of partners & less condom 
use[18-21] . 
  Many studies have shown a link between risky sexual 
behaviour and alcohol and substance abuse use in HIV 
positive and HIV negative people[22-25]. Some studies have 
suggested there is a link between poor adherence to ART and 
increased rates of unprotected sexual intercourse [26, 27], 
but data from resource limited settings is limited. Poor 
adherence could be related to erratic lifestyle and health 
choices; condom use can also be affected by these factors so 
one could predict the other. Patients with worse adherence 
are more likely to have detectable VLs, if they then have 
unsafe sex they could potentially transmit drug-resistant HIV 
[28]. A study in USA showed an association between poor 24    The Open Virology Journal, 2012, Volume 6  Clarke et al. 
adherence, perceived HIV viral load and increased number 
of sexual partners [18]. 
  Few studies regarding adherence in Thailand have been 
reported; one showed good levels [29] but did not assess any 
correlation with unprotected sex risk. Our study aimed to 
assess the association in the levels of adherence in 
chronically infected Thai HIV positive people on stable ART 
and risky sexual behaviour which could lead to HIV 
transmission. It also explored use of alcohol, recreational 
drugs and patients’ beliefs regarding HIV transmission and 
whether these were related to having unprotected sex. 
METHODS 
  This cross sectional study had ethical approval in both 
Thailand and Australia. All patients attending a research 
clinic in Bangkok, who were either on an active clinical trial 
or on lifelong follow-up post clinical trial and taking ART 
for at least 6 months between August 2007 and November 
2007, were invited to join the study. Participants were asked 
to fill out an anonymous, self administered questionnaire in 
Thai regarding their relationship details, ART adherence, 
sexual behaviour, alcohol and drug use[30]. Adherence in 
the previous 30 days was assessed using a visual analogue 
scale (VAS) where patients indicated on a graduated line 
how often in the past month they took their ART from 0% 
(never took it) to 100% (did not miss a dose). Risk 
behaviours were assessed using questions adapted from 
validated questionnaires previously used in Thailand [31-
33]. This included questions regarding sexual activity in the 
last 30 days in terms of frequency, numbers/type of partners 
and condom use. Beliefs regarding HIV transmission were 
ascertained. A study team member accessed patient notes 
and computer results system for additional information about 
medical history and VL/CD4 results closest to date of 
questionnaire completion. Patients were defined as having 
unprotected sex risk (USR) if they had any unprotected sex 
with partners of negative or unknown HIV status in the last 
30 days. Patients had no financial compensation for 
partaking in the study. This study is registered at 
www.clinicaltrial.gov number NCT00511056. 
Statistical Analysis 
  Questionnaire responses were entered into a database and 
patient characteristics were summarised and frequency tables of 
questionnaire responses were constructed. Whether a patient 
met our definition of unprotected sex risk (USR) or not was 
used as the outcome variable in logistic regression models. 
Covariates assessed for their predictive value were age, gender, 
education, income, years since HIV diagnosis, years on ART, 
adherence (dichotomised as good, VAS>95%, or bad, VAS 
<=95% adherence), type of partner, Viral load results, alcohol & 
drug use, belief about HIV transmission in relation to VL or 
ART. Covariates significant at the level of 0.1 were used to 
construct a multivariate model. Statistical analysis was conduc-
ted using STATA 11.2 (Statacorp, College Station, Tx, USA) 
RESULTS 
Demographics 
  Five hundred and twelve patients completed the 
questionnaire and characteristics are summarised in Table 1. 
The median age was 39 years, 286 (56%) were male. Four 
hundred and thirty five (85%) patients identified themselves 
heterosexual, 61 (12%) men who had sex with men (MSM) 
and 15 (3%) bisexual. The median current CD4 cell count 
was 511 (IQR 378 – 669) cells/mm
3; 489 (96%) had a 
VL<50copies/mL. Median length of time since HIV 
diagnosis was 7 (IQR 4 – 9) years and median duration on 
ART was 5 (IQR 3 – 7) years. Most patients (71%) were 
earning <10,000 THB per month (approx 330 USD). 
Table 1.  Demographics & HIV Characteristics (n=512) 
 
Gender 
Male 
female 
n,% 
286 (56) 
226 (44) 
Age in years 
Median (IQR)  
 
39 (35 – 45), range 24 - 66 
Sexuality 
Heterosexual 
MSM 
Bisexual 
Refused to answer 
n,% 
435 (85) 
61 (12) 
15 (3) 
1  
Education –highest level attained 
Primary school 
High school 
College 
Bachelor degree 
Masters/doctorate 
No answer 
n,% 
134 (26) 
143 (28) 
110 (21) 
116 (23) 
7 (1.5) 
2 (0.5) 
Income (Thai baht/month) 
<5,000 
5,001-10,000 
10,001-20,000 
>20,000 
No answer 
n,% 
171 (33) 
198 (39) 
103 (20) 
31(6) 
9 (2) 
Current CD4 (cells/mm
3) 
Median (IQR) 
 
511 (378-669) 
Viral load, copies/mL 
<50 
>50 & <200 
>200 
n,% 
489 (96) 
9 (2) 
14 (2) 
Years since HIV diagnosis 
Median (IQR) 
 
7 (4 – 9) 
Years of ART 
Median (IQR) 
5 (3 – 7 ) 
Numbers may vary due to missing data. 
 
Partner Information 
  Three hundred and forty (66%) reported having partners: 
178 (35%) had a partner who was also HIV positive, 109 
(21%) HIV negative partners and 53 (10%) partners were of 
unknown HIV status. Two hundred and seventy five (80%) 
had disclosed their HIV status to partners. 
ART Adherence 
  According to self-reported adherence by VAS, 288 
(57%) patients took >=95%, 178 (35%) took between 80 to Adherence and Risk Behaviour in Bangkok  The Open Virology Journal, 2012, Volume 6    25 
<95% and 42/508 (8%) took <80% of prescribed doses in the 
previous month. Eleven out of 14 patients with a VL 
>200copies/mL had a VAS<95%. The odds ratio for having 
a detectable VL >200 copies/mL with an adherence cut point 
of <95% on VAS was 5.0 (95%CI 1.4 – 18.2); p = 0.01. In 
the 236 patients who had recently missed dose(s) or taken 
doses more than 1hour late, the commonest reasons given 
were forgetting to take the medicines with them (51%) and 
travelling away from home (40%). 
Sexual Behaviour 
  In the previous 30 days, 298 (58%) patients had engaged 
in sex. For 224 (75%) this was with a regular partner/s and 
68 (23%) with a non primary partner (8 did not respond). 
  Most patients (255, 86%) had had sex with only one 
partner in the last 30 days, 22 (7%) with 2 partners and 6 
patients with 3 or more partners (including one patient with 
10 partners). Condoms were consistently used by 240 
respondents (81%). Reasons given for not using a condom 
were most commonly due to lack of availability/preparation 
(28%) and the respondent or partner not liking using 
condoms (34%). See Table 2. 
Table 2.  Condom Use and Reasons for Non Use in Last 30 
Days in the 298 Sexually Active Patients 
 
Condom use (n,%) 
Always 
Almost always 
Sometimes 
Never 
No answer given 
 
240(81) 
16(5) 
22(7) 
18(6) 
2(1) 
Reasons for not using a condom in last 30 days*, n(%) 
Condoms do not feel natural/partner does not like 
Condoms were not available/I did not prepare for using a condom 
Partner also HIV positive so do not use 
Trying to conceive 
Believing that being on HAART will not spread/acquire HIV 
Fear of partner knowing HIV status 
Being drunk 
 
26(34) 
21(28) 
14(18) 
5(7) 
4(5) 
4(5) 
2(3) 
*Patients could give more than one reason. 
 
Alcohol and Drug Use 
  When asked about alcohol intake in the last 30 days, 326 
(64%) had had none, 140 (27%) had alcohol once or less a 
week, 32 (6%) 2-3 times per week and 9 (2%) had it 4 or 
more times per week. Sixty-eight patients had alcohol 
before/during sex in the last 30 days and of these 15 (22%) 
did not subsequently consistently use a condom. Nine had 
HIV-positive partners, 5 had HIV-negative/unknown status 
partners (1 refused to answer). 
  Recreational drugs were used by 10 (2%) patients,  once 
a week in all. Three used marijuana, 2 benzodiazepines, 1 
poppers and the others did not specify what drug(s) was 
used. Four of ten (40%) used these drugs before or during 
sex and 2 patients did not always subsequently use condoms. 
Both of these had VL < 50 copies/mL and one had a partner 
of unknown HIV status. 
 
Patients with Unprotected Sex Risk (USR) 
  Twenty seven patients (5%) fitted the criteria of having a 
USR, i.e., having any unprotected sex with a partner of 
negative or unknown HIV status in the last 30 days: 18(67%) 
were women; 9 were men (6 heterosexual, 2 MSM, 1 
bisexual). All had undetectable viral loads and had been on 
HAART for at least 2 years. VAS results showed 46% 
reported adherence 95%; this was not significantly different 
to the non-USR population (p=0.2). Twenty (77%) were 
having sex with their primary partners and 6 with non-
primary/casual partners (1 no answer). The commonest 
reason given for not using a condom was that their partner 
did not like using condoms (11, 41%); 9(33%) said that no 
condoms were available/they didn’t prepare for condom and 
2 women did not use a condom for fear of partner 
discovering status. No USR patients were trying to conceive 
or believed that being on ART meant they would not spread 
HIV or were drunk when they had unprotected sex. 
Seventeen (63%) patients with USR had disclosed their HIV 
status to their primary partner. In univariate analysis USR 
was not associated with poor ART adherence (VAS either 
<80 or 95%), alcohol/drug use, casual partners, time on ART 
or the belief that being on ART prevented transmitting HIV 
(see Table 3). Younger age (<40years), low education, lower 
income and female gender were all associated with USR, but 
after adjustment in a multivariate model, only female gender 
was significant (odds ratio 2.9; 95% confidence interval [CI] 
1.2 -7.0; P = 0.02). 
Patients’ Beliefs Regarding HIV Transmission and 
HAART 
  When asked if taking HIV medicine reduces the threat of 
transmitting HIV to others 132 (26%) agreed, 286 (56%) did 
not and 90 (18%) were unsure. When asked if they thought 
that having an undetectable viral load (<50 copies) reduces 
the threat of transmitting HIV to others 99 (19%) agreed, 
294 (57%) disagreed and 114 (22%) were unsure. When 
asked if taking HIV medicine reduces their concerns about 
having sex without using a condom 31 (6%) said yes , 424 
(83%) said no and 49 (10%) were unsure. 
DISCUSSION 
  The adherence rates in our cohort were lower than 
expected with only 57% reporting adherence of 95% in the 
last 30 days on the visual analogue scale, but despite this the 
viral loads in our cohort were suppressed in the majority 
(96%) of patients. This finding agrees with other studies 
noting that the current more potent ART may be more 
forgiving than previously thought[3]. Unsurprisingly patients 
reporting a VAS <95% had a higher rates of viral loads 
>200copies/mL (OR 5.0). A small number of the patients 
with very low reported adherence (i.e. 5-45% on VAS) had 
undetectable viral loads so miscomprehension of the VAS 
instructions is a possible explanation although it has 
previously been well understood in a similar patient 
group[34]. Conversely some patients with excellent reported 
adherence had detectable VLs but may have been on failing 
regimes and waiting for regimen change or resistance results. 
Pill counts were not done to confirm reported adherence. 
Reasons for forgetting ART were in the majority practical 
issues of forgetting to bring the medications with them and  
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travelling away from home. This could be potentially be 
remedied by providing easier more discreet packaging i.e. 
small pill boxes that can be kept in a pocket/bag at all times. 
  More than half (58%) of the patients were sexually active 
in the last 30 days and in the majority (80%) a condom was 
always used; this rate of condom use is higher than found in 
cohorts in Kenya (72%) and Uganda (66%) [35, 36]. In those 
56(19%) who did not always use a condom, more than half 
had a known HIV positive partner. The risk of an HIV 
positive person potentially passing on or acquiring another 
HIV virus appears to be minimal and the larger concern in 
this small group of seroconcordent couples would be 
acquiring sexually transmitted diseases and for females of 
becoming pregnant[37, 38]. Indeed, trying to conceive was a 
reason for non condom use in nearly 7%. Information on 
type of sex was not collected but each type is known to have 
different risks [39, 40]. Interestingly nearly 28% of patients 
reported the lack of availability and/or lack of planning as a 
reason for non condom use. Condoms are given out for free 
to all patients in the HIV clinic so it is more likely that the 
lack of planning for sexual activity was the cause and 
patients need to be encouraged to carry condoms on them to 
be prepared. 
  Only 27 out of 512 (5%) were classified as USR (having 
had any unprotected sexual intercourse with a partner of 
negative or unknown HIV status in the last 30days). This is 
reassuringly low. The adherence in this group of patients was 
lower (46 vs 57%) than non-USR patients but this was not 
statistically significant and indeed despite this all USR 
patients had VL <50copies/mL . No information on sexually 
transmitted diseases was available but a previous study of 
824 HIV positive asymptomatic patients in Bangkok showed 
Chlamydia trachomatis rates of 9.7% and Neisseria 
gonorrhoeae of 1.3%, with a high disease burden in sex 
workers and in younger patients; it is likely our cohort would 
have lower rates than this with an older median age 
(39years) and no sex workers [41]. Genital HIV RNA levels 
were not collected and the true potential infectivity of this 
small but important group of patients in this cohort is 
unknown but likely to be very small. Contrary to 
expectations there was no association of USR and poor 
adherence in this group. This association may not have been 
found due to small patient numbers exhibiting USR but may 
indicate that the unprotected sex was not due to ‘erratic’ 
lifestyles but rather due to other sex-related factors such as 
condom issues and HIV disclosure concerns. Indeed 40% 
reported their partner’s dislike of condoms as the reason for 
unprotected sexual intercourse. This exemplifies the 
complex nature of sexual risks including the importance of 
condom negotiation skills, particularly for women (who 
made up 67% of USR). Female gender was the only factor 
associated with increased risk of USR (OR 2.9). Ragnarsson 
et al., recently reported a similar finding in a cohort in 
Kenya with female gender having an OR of 3.03 for 
inconsistent condom use [35]. This group suggested possible 
reasons for their finding being a lack of individual 
negotiating power in intimate relationships and also 
reproductive desires; in our study none of the USR women 
reported reproductive desire as their reason for non condom 
use so difficulty with condom negotiation or partner choice 
are likely factors in our cohort and further work needs to be 
done e.g. acceptability testing of other barrier methods such 
as the female condom and teaching condom negotiation 
techniques. 
  In the questions regarding beliefs only 26% patients 
thought that taking ART would reduce transmission of HIV 
yet even fewer patients believed that having an undetectable 
viral load would affect HIV transmission. This study was 
carried out when there was less evidence regarding ART and 
HIV transmission, also many of the patients in the cohort 
have low incomes and may not have access to the latest HIV 
news e.g. through the internet and networks, to guide their 
decision making in unprotected sex risk. Medical staff 
discussing latest scientific information regarding 
transmission with patients need to clearly state the evidence 
so far and carefully tailor their advice to a patient’s 
Table 3.  Predictive Factors for Unprotected Sex Risk (USR) in the Previous 30 Days 
 
Univariate Multivariate 
Risk Factor 
OR (95% CI)  P  OR (95% CI)  P 
Female gender  4.2 (1.8 – 9.8)  0.001  2.9 (1.2 -7.0)  0.02 
Primary school education or less  2.6 (1.1 – 5.9)  0.02  1.9 (0.7 – 4.7)  0.19 
Age <40years  3.2 (1.2 - 8.6)  0.03  2.3 (0.79 – 6.5)  0.13 
Low income<5,000THB/month  2.7 (1.2 – 6.1)  0.02  1.6 (0.65 – 4.1)  0.29 
More than 1 partner in last 30 days  1.03 (0.34 – 3.15)  0.95    
Any alcohol in last 30 days  1.1 (0.51 – 2.47)  0.78     
Recreational drug use in last 30 days  3.1 (0.62 – 16.0)  0.17     
Taking HAART for  2 years  0.97 (0.39 – 2.38)  0.94    
< 95% adherence on VAS  1.6 (0.7 – 3.5)  0.27     
< 80% adherence on VAS  1.4 (0.4 – 5.0)  0.61     
Sex with primary (vs non-primary) partner  0.80 (0.32 – 1.90)  0.61    
Believing transmission is reduced if on HAART & viral load <50 copies/mL  0.98 (0.35 – 2.71)  0.97    Adherence and Risk Behaviour in Bangkok  The Open Virology Journal, 2012, Volume 6    27 
individual situation to ensure partners are not inadvertently 
put at risk. 
  Only a small proportion of patients reported recreational 
drug use and over 2/3 did not drink alcohol; this implies that 
this cohort is not a high ‘risk taking’ group, either because of 
self selection by being someone willing to enter into a 
clinical trial or due to the regular counselling and advice 
given regarding risk behaviours, or likely a combination of 
both these factors. Of those who drank alcohol around the 
time of sex 22% did not subsequently use a condom and this 
supports findings of many other studies showing alcohol 
intake can lead to subsequent unsafe sexual practises[23, 24]. 
  Limitations of this study include the fact that this was 
performed in a research setting so results may not be 
transferable to the general population where less intense 
medical input and counselling related to sexual risk and 
adherence may occur. Patients were only asked about sexual 
activity in the last 30 days which may have underestimated 
true sexual activity and hence risk behaviour in the cohort. 
The number of MSM in the cohort was low reflecting the 
epidemic of HIV in Thailand being largely heterosexual. 
  In summary unprotected sex risk was uncommon 
(27/512, 5%) and poor ART adherence was not associated 
with USR in this resource limited cohort. Women were 
significantly more likely to have USR and more work needs 
to be done to help women in condom negotiation particularly 
in serodiscordant relationships. HIV prevention strategies 
need to be focused on high transmission risk groups to be 
maximally effective (i.e. patients not on ART, 
seroconverting patients, undiagnosed patients) and this 
outpatient clinic cohort appears to have a reassuring low, 
although not negligible, risk of transmission. 
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